The Manufacturers Life Insurance Company Invests $580,000 in Medical Properties Trust, Inc. $MPT

The Manufacturers Life Insurance Company bought a new stake in Medical Properties Trust, Inc. (NYSE:MPT) in the second quarter, HoldingsChannel.com reports. The firm bought 125,604 shares of the company’s stock, valued at approximately $580,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Visionary Wealth Advisors acquired a new stake in Medical Properties Trust in the 2nd quarter worth about $102,000. Sanctuary Advisors LLC acquired a new position in shares of Medical Properties Trust during the 2nd quarter worth approximately $81,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Medical Properties Trust during the 2nd quarter worth approximately $530,000. Quantbot Technologies LP bought a new position in shares of Medical Properties Trust during the second quarter worth approximately $363,000. Finally, Evolve Private Wealth LLC bought a new position in shares of Medical Properties Trust during the second quarter worth approximately $164,000. 71.79% of the stock is currently owned by institutional investors and hedge funds.

Medical Properties Trust Stock Up 0.2%

MPT stock opened at $4.02 on Monday. The firm has a 50-day moving average price of $4.44. The company has a market cap of $2.40 billion, a price-to-earnings ratio of -67.00 and a beta of 1.40. The company has a current ratio of 3.12, a quick ratio of 3.12 and a debt-to-equity ratio of 2.16. Medical Properties Trust, Inc. has a 12 month low of $3.89 and a 12 month high of $6.47.

Medical Properties Trust (NYSE:MPT) last issued its quarterly earnings results on Monday, August 10th. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. The company had revenue of $259.28 million during the quarter. Medical Properties Trust had a negative net margin of 2.96% and a negative return on equity of 0.66%. The firm’s revenue was up 7.9% on a year-over-year basis. Equities analysts predict that Medical Properties Trust, Inc. will post 0.6 EPS for the current year.

Medical Properties Trust Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 8th. Shareholders of record on Thursday, September 10th will be given a dividend of $0.09 per share. This represents a $0.36 annualized dividend and a yield of 9.0%. The ex-dividend date is Thursday, September 10th. Medical Properties Trust’s payout ratio is currently -600.00%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Wells Fargo & Company cut their price target on Medical Properties Trust from $5.00 to $3.80 and set an “underweight” rating for the company in a research note on Tuesday, September 1st. Weiss Ratings lowered Medical Properties Trust from a “sell (d+)” rating to a “sell (d)” rating in a research note on Tuesday, August 18th. Finally, Royal Bank Of Canada dropped their price objective on Medical Properties Trust from $5.00 to $4.50 and set a “sector perform” rating for the company in a report on Thursday, June 18th. One research analyst has rated the stock with a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Sell” and a consensus price target of $4.15.

About Medical Properties Trust

Medical Properties Trust, Inc (NYSE: MPT) is a real estate investment trust (REIT) that acquires, owns and finances hospitals and other healthcare facilities. Founded in 2003 by Edward K. Aldag Jr., the company’s business model centers on providing real estate capital to healthcare operators through long-term leases, sale-leaseback transactions, build-to-suit developments and mortgage financing. By specializing in healthcare real estate, MPT aims to deliver steady rental income and asset-based returns while enabling operators to access capital for clinical operations and growth.

The company’s portfolio primarily comprises acute care hospitals, inpatient rehabilitation hospitals, long-term acute care facilities, behavioral health centers and other specialty hospitals.